Karyopharm Therapeutics Inc. - Wikirate, an Open ESG Data Platform

RESOURCES
Guides
API
FAQ
Recent Changes
Report Issue
ABOUT
About Wikirate
Community
Data
Impact

arrow_back_ios

Research Groups

arrow_forward_ios

Home
Companies
Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc.

performance profile

WikiRate ID: 3075698

Headquarters: Massachusetts (United States)

Answers 148
Sources 11
Groups 1
Data Sets 0
Details

Filters

Answers

148

Metrics

28

Years

12

Sort

2022

US Securities and Exchange Commission+Image

Comprehensive Income Net of Tax

-166M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

358M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Deferred Income Tax Expense Benefit

0 USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Effective Income Tax Rate Continuing Operations

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Income Loss From Continuing Operations Before Income Taxes Foreign

892,000 USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Income Tax Expense Benefit

369,000 USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

375M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

-165M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Operating Expenses

299M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Operating Income (Loss)

-142M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Payments for Royalties

29.3M USD

Open in full page

Open in new window

2022

US Securities and Exchange Commission+Image

Research and Development Expense

149M USD

Open in full page

Open in new window

2021

85 WELLS AVENUE, NEWTON, 02459

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Comprehensive Income Net of Tax

-124M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Net Income Attributable to the company

-124M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

305M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Deferred Income Tax Expense Benefit

0 USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Effective Income Tax Rate Continuing Operations

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Income Loss From Continuing Operations Before Income Taxes Foreign

-30.1M USD

Open in full page

Open in new window

2021

US Securities and Exchange Commission+Image

Income Tax Expense Benefit

268,000 USD

Open in full page

Open in new window

1
2
3
...
8

1 - 20 of 148

Export Toggle Dropdown

Export Data

Format

Detail

Answers

Cancel

Applying Attribution

Using this data requires appropriate attribution.

How to attribute

Wikirate, an initiative of Wikirate International e.V., is an open data platform powered by its community.

legal

Wikirate Policies Privacy Policy Terms of Use Impressum

contact

Contact us on Wikirate international Subscribe for Updates

follow us

We're on Decko

WikiRate's content is licensed under CC BY 4.0, and the database infrastructure under CC BY-SA 4.0. Read more about licensing.